Jan. 9, 2024
by Andrii Buvailo
Biopharma insight
In a notable advancement for the fast-moving consumer goods (FMCG) industry, Spore.Bio, a deeptech startup, has recently raised €8 million in …
Jan. 7, 2024
by Dana Sokolova
Biopharma insight
With over half of the world's population being female, it's only natural that the world of femtech is experiencing a …
Jan. 5, 2024
by Irina Bilous, Andrii Buvailo
Biopharma insight
The clinical trial is a critical stage of drug development workflow, with an estimated average success rate of about 11% …
Dec. 28, 2023
by Andrii Buvailo
Biopharma insight
For many years the focus of therapeutic developments and scientific research was directed at the genome and proteins. Yet, there …
Dec. 27, 2023
by Andrii Buvailo
Biopharma insight
The biopharma industry experienced a challenging year in 2023, marked by a significant decrease in funding and a high number …
Dec. 26, 2023
by Andrii Buvailo
Biopharma insight
In the current climate of global economic uncertainty, one area of pharmaceutical development is bucking the trend with a significant …
Dec. 24, 2023
by Andrii Buvailo
Biopharma insight
(Last Update: December 24, 2023, by adding Cromatic.bio) A life sciences marketplace is an online platform that operates with a "many-to-many" business logic, …
Receptor.AI has announced ArtiDock, the best-in-class model for “AI docking," which predicts the binding poses of small molecule ligands in protein …
Nov. 27, 2023
by Andrii Buvailo
Biopharma insight
In recent news, Recursion (NASDAQ: RXRX), a prominent clinical stage TechBio firm, has announced the signing of agreements to acquire …
Nov. 17, 2023
by Andrii Buvailo
Biopharma insight
Companies are increasingly turning to generative artificial intelligence (AI) to develop new therapeutics, giving biotech companies with patents on these …
Nov. 7, 2023
by Tim Sandle
Biopharma insight
The digital transformation of biopharmaceutical manufacturing has continued at a rapid pace as companies mine the rich sources of data …
Nov. 3, 2023
by Andrii Buvailo
Biopharma insight
The first biologics drug, humanized insulin (5.8 kDa), became available in 1982 following the advent of biotechnology, and it marked …